This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Recognition and Assessment of Sexual Dysfunction Associated With Depression

Anita H. Clayton

Published: February 1, 2001

Article Abstract
Recognition of sexual dysfunction associated with depression or its treatment is critical for patient satisfaction and medication compliance. This report reviews relevant literature related to types of sexual problems, the etiology of sexual dysfunction, prevalence rates, barriers to assessment, and available instruments for evaluating sexual functioning in individuals with depression. Evaluation of sexual functioning should include examination of each phase of the sexual response cycle, with classification of sexual disorders as described in the DSM-IV. Sexual functioning requires both an adequate hormonal milieu and appropriate neurotransmitter functioning. Evaluation of sexual functioning should include a sexual history, current level of sexual functioning, history and current diagnoses of medical and psychiatric illnesses, evaluation of medications and/or other substances taken, indicated endocrine measures, and targeted physical examination. Appropriate evaluation of sexual functioning associated with depression could help reduce the enormous societal costs of this disorder.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 3

Quick Links: Depression (MDD)


Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...